Our clinical trial found that early use of convalescent plasma may help outpatients with COVID-19 avoid hospitalization.
Read more below:

On March 30, 2022 the results from the early treatment clinical trial were published in the New England Journal of Medicine (NEJM):

On March 29, 2022, a guide for implementing a plasma transfusion center for outpatients with COVID-19, including logistical, staffing and blood banking requirements was published in the journal Transfusion.

The trial stopped enrollment on October 1.

You should also contact your physician to see if you qualify for monoclonals which are an antibody alternative.